NL1031473A1 - Cyclopentapyridine- en tetrahydrochinolinederivaten. - Google Patents

Cyclopentapyridine- en tetrahydrochinolinederivaten.

Info

Publication number: NL1031473A1
Authority: NL; Netherlands
Prior art keywords: cyclopentapyridine; tetrahydroquinoline derivatives; tetrahydroquinoline; derivatives
Prior art date: 2005-03-31

Application number

NL1031473A

Other languages

English (en)

Other versions

NL1031473C2 (nl

Inventor

Hou Chen

Steven Blair Coffey

Kevin Kun-Chin Liu

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-31

Filing date

2006-03-30

Publication date

2006-10-03

2006-03-30 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2006-10-03 Publication of NL1031473A1 publication Critical patent/NL1031473A1/nl

2007-03-19 Application granted granted Critical

2007-03-19 Publication of NL1031473C2 publication Critical patent/NL1031473C2/nl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Gynecology & Obstetrics (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Other In-Based Heterocyclic Compounds (AREA)

NL1031473A 2005-03-31 2006-03-30 Cyclopentapyridine- en tetrahydrochinolinederivaten. NL1031473C2 (nl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US66718405P	2005-03-31	2005-03-31
US66718405		2005-03-31
US76215906P	2006-01-26	2006-01-26
US76215906		2006-01-26

Publications (2)

Publication Number	Publication Date
NL1031473A1 true NL1031473A1 (nl)	2006-10-03
NL1031473C2 NL1031473C2 (nl)	2007-03-19

Family

ID=36218589

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL1031473A NL1031473C2 (nl)	2005-03-31	2006-03-30	Cyclopentapyridine- en tetrahydrochinolinederivaten.

Country Status (24)

Country	Link
US (1)	US7507732B2 (nl)
EP (1)	EP1869000A1 (nl)
JP (1)	JP4318744B2 (nl)
KR (1)	KR100894006B1 (nl)
AP (1)	AP2007004144A0 (nl)
AR (1)	AR054021A1 (nl)
AU (1)	AU2006228378A1 (nl)
BR (1)	BRPI0609268A2 (nl)
CA (1)	CA2602348C (nl)
CR (1)	CR9386A (nl)
DO (1)	DOP2006000076A (nl)
EA (1)	EA200701853A1 (nl)
GT (1)	GT200600128A (nl)
IL (1)	IL185492A0 (nl)
MA (1)	MA29354B1 (nl)
MX (1)	MX2007012082A (nl)
NL (1)	NL1031473C2 (nl)
NO (1)	NO20074368L (nl)
NZ (1)	NZ560917A (nl)
PE (1)	PE20061333A1 (nl)
TN (1)	TNSN07367A1 (nl)
TW (1)	TW200722423A (nl)
UY (1)	UY29446A1 (nl)
WO (1)	WO2006103511A1 (nl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2007516289A (ja)	2003-12-23	2007-06-21	ミオゲンインコーポレイティッド	心血管および筋疾患治療のための５−ｈｔ２受容体調節物質、それらの薬学的組成物およびそれらの使用
EP1844792A4 (en) *	2004-12-14	2008-05-21	Shionogi & Co	THERAPEUTIC AGENT AGAINST OBSTIPATION
EP2742936A1 (en)	2006-05-16	2014-06-18	Takeda Pharmaceutical Company Limited	Fused heterocyclic compound and use thereof
DE602007012254D1 (de) *	2006-07-14	2011-03-10	Pfizer Prod Inc	Tartratsalz von (7s)-7-ä(5-fluor-2-methylbenzyl)oxyü-2-ä(2r)-2-methylpiperazin-1-ylü-6,7-dihydro-5h-cyclopentaäbüpyridin
MX2009001043A (es)	2006-08-08	2009-02-06	Sanofi Aventis	Imidazolidina-2,4-dionas sustituidas con arilaminoarilalquilo, procedimiento para preparalas, medicamentos que comprenden estos compuestos y su uso.
JP5031846B2 (ja)	2006-12-07	2012-09-26	エフ．ホフマン−ラロシュアーゲー	５−ｈｔ（５ａ）受容体アンタゴニストとしての２−アミノキノリン
WO2009063992A1 (ja)	2007-11-15	2009-05-22	Takeda Pharmaceutical Company Limited	縮合ピリジン誘導体およびその用途
JP2011514898A (ja)	2008-03-07	2011-05-12	エフ．ホフマン−ラロシュアーゲー	２−アミノキノリン誘導体
JP2010043063A (ja)	2008-05-09	2010-02-25	Agency For Science Technology & Research	川崎病の診断及び治療
US8470841B2 (en)	2008-07-09	2013-06-25	Sanofi	Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
MX2012001729A (es)	2009-08-26	2012-06-13	Sanofi Sa	Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo.
JO3250B1 (ar)	2009-09-22	2018-09-16	Novartis Ag	إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
EP2510949A4 (en)	2009-12-11	2013-11-13	Astellas Pharma Inc	THERAPEUTICS FOR FIBROMYALGIA
US8674218B2 (en)	2010-12-15	2014-03-18	General Electric Company	Restraint system for an energy storage device
EP2683704B1 (de)	2011-03-08	2014-12-17	Sanofi	Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683700B1 (de)	2011-03-08	2015-02-18	Sanofi	Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683699B1 (de)	2011-03-08	2015-06-24	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120052A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120054A1 (de)	2011-03-08	2012-09-13	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2015066344A1 (en)	2013-11-01	2015-05-07	Arena Pharmaceuticals, Inc.	5-ht2c receptor agonists and compositions and methods of use
US20210052600A1 (en)	2017-12-27	2021-02-25	Takeda Pharmaceutical Company Limited	Therapeutic agents for stress urinary incontinence and incotinence of feces
CN110236526B (zh) *	2019-06-28	2022-01-28	李秋	基于咀嚼吞咽动作及心电活动的摄食行为分析和检测方法
WO2024026423A1 (en) *	2022-07-27	2024-02-01	Black Diamond Therapeutics, Inc.	Substituted quinoline derivatives as pi3k inhibitors

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH01211581A (ja)	1988-02-18	1989-08-24	Meiji Seika Kaisha Ltd	シクロペンテノピリジン誘導体および抗潰瘍剤
US4985352A (en)	1988-02-29	1991-01-15	The Trustees Of Columbia University In The City Of New York	DNA encoding serotonin 1C (5HT1c) receptor, isolated 5HT1c receptor, mammalian cells expressing same and uses thereof
US5019574A (en)	1988-09-30	1991-05-28	Chugai Seiyaku Kabushiki Kaisha	3,4-diaminoquinoline and 3,4-diamino-5,6,7,8-tetrahydroquinoline compounds useful for improving psychoneural function
ATE107922T1 (de)	1989-03-03	1994-07-15	Dainippon Pharmaceutical Co	2-(1-piperazinyl)-4-phenylcycloalkanpyridin- derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
JP2660086B2 (ja)	1990-07-03	1997-10-08	明治製菓株式会社	脳及び心機能障害改善剤
JPH04103572A (ja)	1990-08-20	1992-04-06	Dainippon Pharmaceut Co Ltd	４―フェニル―２―（１―ピペラジニル）ピリジン誘導体
EP0572863A1 (de)	1992-06-05	1993-12-08	F. Hoffmann-La Roche Ag	ZNS Pyrazinoindole
DE4326151A1 (de)	1993-08-04	1995-02-09	Hoechst Ag	Aromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
TW270114B (nl)	1993-10-22	1996-02-11	Hoffmann La Roche
TW334423B (en)	1993-10-22	1998-06-21	Hoffmann La Roche	Tricyclic 1-aminoethylpyrrole-derivatives
US5698766A (en)	1995-04-05	1997-12-16	The Regents Of The University Of California	Transgenic animal model for testing drugs for treating eating disorders and epilepsy
TW477787B (en)	1996-08-27	2002-03-01	Pfizer	Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
JP3560986B2 (ja)	1997-01-13	2004-09-02	山之内製薬株式会社	５―ｈｔ２ｃ受容体作用薬及びアミノアルキルインダゾール誘導体
ATE250573T1 (de)	1997-02-25	2003-10-15	Akzo Nobel Nv	Azetidin- und pyrrolidinderivate
US6322738B1 (en)	1997-07-24	2001-11-27	Husky Injection Molding Systems Ltd.	Method of injection over-molding articles
EP1025097B1 (en)	1997-10-24	2005-04-27	Neurogen Corporation	1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d 4? receptor subtype ligands
US6040448A (en)	1997-10-24	2000-03-21	Neurogen Corporation	Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands
AU4037699A (en)	1998-05-08	1999-11-29	Akzo Nobel N.V.	Novel aryl-hydro naphthalenal kanamines
GB9819035D0 (en)	1998-09-01	1998-10-28	Cerebrus Res Ltd	Chemical compounds VII
GB9819020D0 (en)	1998-09-01	1998-10-28	Cerebrus Ltd	Chemical compounds III
GB9819033D0 (en) *	1998-09-01	1998-10-28	Cerebrus Ltd	Chemical compounds VI
WO2000012077A1 (en)	1998-09-01	2000-03-09	Bristol-Myers Squibb Company	Potassium channel inhibitors and method
GB9819019D0 (en)	1998-09-01	1998-10-28	Cerebrus Ltd	Chemical compounds II
JP2000191533A (ja)	1998-10-19	2000-07-11	Eisai Co Ltd	鎮痛剤
AU1738900A (en)	1998-11-19	2000-06-05	Nortran Pharmaceuticals Inc.	Serotonin ligands as pro-erectile compounds
WO2000044737A1 (en)	1999-01-27	2000-08-03	Eli Lilly And Company	Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists
IL146582A0 (en)	1999-05-21	2002-07-25	Biovitrum Ab	Novel compounds, their use and preparation
CN1555387A (zh) *	2000-07-28	2004-12-15	古德里奇公司	制造光学波导管的聚合物组合物、由此制造的光学波导管及制造此波导管的方法
SE0004245D0 (sv) *	2000-11-20	2000-11-20	Pharmacia Ab	Novel compounds and their use
CA2448729A1 (en)	2000-11-20	2002-05-23	Biovitrum Ab	Piperazinyl and piperidyl substituted heterocyclic compounds
TWI245761B (en)	2001-03-01	2005-12-21	Telik Inc	Antagonists of MCP-1 function and methods of use thereof
EP1767525A1 (en)	2001-04-09	2007-03-28	Novartis Vaccines and Diagnostics, Inc.	Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists
US6825198B2 (en)	2001-06-21	2004-11-30	Pfizer Inc	5-HT receptor ligands and uses thereof
US6953787B2 (en)	2002-04-12	2005-10-11	Arena Pharmaceuticals, Inc.	5HT2C receptor modulators
WO2004091485A2 (en)	2003-04-11	2004-10-28	Taigen Biotechnology	Aminoquinoline compounds
US7101881B2 (en)	2003-06-11	2006-09-05	Pfizer Inc	Tetrahydroquinolines
TW200612918A (en)	2004-07-29	2006-05-01	Threshold Pharmaceuticals Inc	Lonidamine analogs

2006
- 2006-03-21 CA CA2602348A patent/CA2602348C/en not_active Expired - Fee Related
- 2006-03-21 EP EP06710585A patent/EP1869000A1/en not_active Withdrawn
- 2006-03-21 AP AP2007004144A patent/AP2007004144A0/xx unknown
- 2006-03-21 BR BRPI0609268-3A patent/BRPI0609268A2/pt not_active IP Right Cessation
- 2006-03-21 EA EA200701853A patent/EA200701853A1/ru unknown
- 2006-03-21 KR KR1020077022374A patent/KR100894006B1/ko not_active IP Right Cessation
- 2006-03-21 WO PCT/IB2006/000655 patent/WO2006103511A1/en not_active Application Discontinuation
- 2006-03-21 MX MX2007012082A patent/MX2007012082A/es active IP Right Grant
- 2006-03-21 JP JP2008503608A patent/JP4318744B2/ja not_active Expired - Fee Related
- 2006-03-21 NZ NZ560917A patent/NZ560917A/en not_active IP Right Cessation
- 2006-03-21 AU AU2006228378A patent/AU2006228378A1/en not_active Abandoned
- 2006-03-28 PE PE2006000343A patent/PE20061333A1/es not_active Application Discontinuation
- 2006-03-29 GT GT200600128A patent/GT200600128A/es unknown
- 2006-03-29 AR ARP060101218A patent/AR054021A1/es unknown
- 2006-03-30 TW TW095111125A patent/TW200722423A/zh unknown
- 2006-03-30 NL NL1031473A patent/NL1031473C2/nl not_active IP Right Cessation
- 2006-03-30 UY UY29446A patent/UY29446A1/es not_active Application Discontinuation
- 2006-03-30 DO DO2006000076A patent/DOP2006000076A/es unknown
- 2006-03-31 US US11/395,327 patent/US7507732B2/en not_active Expired - Fee Related
2007
- 2007-08-23 IL IL185492A patent/IL185492A0/en unknown
- 2007-08-27 NO NO20074368A patent/NO20074368L/no not_active Application Discontinuation
- 2007-09-19 CR CR9386A patent/CR9386A/es not_active Application Discontinuation
- 2007-09-28 MA MA30262A patent/MA29354B1/fr unknown
- 2007-09-28 TN TNP2007000367A patent/TNSN07367A1/fr unknown

Also Published As

Publication number	Publication date
AP2007004144A0 (en)	2007-08-31
KR20070107183A (ko)	2007-11-06
MA29354B1 (fr)	2008-03-03
JP4318744B2 (ja)	2009-08-26
CA2602348A1 (en)	2006-10-05
EA200701853A1 (ru)	2008-08-29
US20060247254A1 (en)	2006-11-02
NZ560917A (en)	2011-01-28
GT200600128A (es)	2007-03-29
EP1869000A1 (en)	2007-12-26
BRPI0609268A2 (pt)	2010-03-09
AU2006228378A1 (en)	2006-10-05
CA2602348C (en)	2011-03-01
WO2006103511A1 (en)	2006-10-05
TNSN07367A1 (fr)	2008-12-31
AR054021A1 (es)	2007-05-30
TW200722423A (en)	2007-06-16
PE20061333A1 (es)	2007-01-13
IL185492A0 (en)	2008-01-06
NO20074368L (no)	2007-09-21
NL1031473C2 (nl)	2007-03-19
US7507732B2 (en)	2009-03-24
UY29446A1 (es)	2006-10-31
CR9386A (es)	2007-10-02
JP2008534568A (ja)	2008-08-28
KR100894006B1 (ko)	2009-04-17
MX2007012082A (es)	2007-11-20
DOP2006000076A (es)	2006-11-30

Publication	Publication Date	Title
NL1031473A1 (nl)	2006-10-03	Cyclopentapyridine- en tetrahydrochinolinederivaten.
NL300935I2 (nl)	2018-10-25	guselkumab.
IS8578A (is)	2006-12-08	3- karbamoýl - 2- pýridón afleiður
DE602006000411D1 (de)	2008-02-21	Sicherheitsflugsitz
EP1882441A4 (en)	2009-10-28	ENDOSCOPE SYSTEM, CONTROL PROGRAM FOR ENDOSCOPE SYSTEM, AND CONTROL METHOD FOR ENDOSCOPE SYSTEM
NL1031218A1 (nl)	2006-08-23	Oxyindoolderivaten.
ATE550315T1 (de)	2012-04-15	Pestizid-bi-phenyl-amidin-derivate
ATE394399T1 (de)	2008-05-15	Tetrahydropyridoindolderivate
DE602006010581D1 (de)	2009-12-31	4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
DK1761541T3 (da)	2008-04-28	Pyrrazolo-pyrimidin-derivater
ATE540935T1 (de)	2012-01-15	Chinazolinderivate
ATE485294T1 (de)	2010-11-15	Azaindol-2-carboxamid-derivate
NL1031627A1 (nl)	2006-10-23	Acylaminobicyclische heteroaromatische verbindingen en toepassingen daarvan.
ATE527255T1 (de)	2011-10-15	Aryl-isoxazol-4-yl-imidazol-derivate
DK1971588T3 (da)	2012-10-22	Tiglien-3-onderivater
NO20051199D0 (no)	2005-03-07	Rorhandteringsutstyr.
ATE417830T1 (de)	2009-01-15	Sulfonylbenzimidazolderivate
DE602005021959D1 (de)	2010-08-05	Substituierte diazaspiroä4.5üdecanderivate und der
NL2000937A1 (nl)	2008-01-11	Piperidinederivaten.
ATE430142T1 (de)	2009-05-15	Phenylpiperazin-methanon-derivate
NO20053362D0 (no)	2005-07-11	Syklofuge.
ATE404542T1 (de)	2008-08-15	4-phenylpyrimidin-2-carbonitrilderivate
ATE541837T1 (de)	2012-02-15	Oxaphenanthren-derivate
ATE365731T1 (de)	2007-07-15	4-amino-5-cyanopyrimidinderivate
EP1799223A4 (en)	2008-01-23	ARYLTHIOBENZYLPIPERIDINE DERIVATIVES

Legal Events

Date	Code	Title	Description
2006-12-01	AD1A	A request for search or an international type search has been filed
2007-01-02	RD2N	Patents in respect of which a decision has been taken or a report has been made (novelty report)	Effective date: 20061116
2007-05-01	PD2B	A search report has been drawn up
2012-10-10	V1	Lapsed because of non-payment of the annual fee	Effective date: 20121001